SG Americas Securities LLC Sells 3,496 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

SG Americas Securities LLC cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 59.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,428 shares of the company’s stock after selling 3,496 shares during the period. SG Americas Securities LLC’s holdings in U.S. Physical Therapy were worth $205,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Truist Financial Corp raised its position in U.S. Physical Therapy by 9.2% in the second quarter. Truist Financial Corp now owns 10,382 shares of the company’s stock worth $960,000 after acquiring an additional 874 shares during the period. Quarry LP raised its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after purchasing an additional 478 shares during the period. The Manufacturers Life Insurance Company raised its position in shares of U.S. Physical Therapy by 4.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock valued at $670,000 after purchasing an additional 309 shares during the period. Marshall Wace LLP raised its position in shares of U.S. Physical Therapy by 1.1% during the 2nd quarter. Marshall Wace LLP now owns 35,392 shares of the company’s stock valued at $3,271,000 after purchasing an additional 378 shares during the period. Finally, Public Sector Pension Investment Board raised its position in shares of U.S. Physical Therapy by 7.8% during the 2nd quarter. Public Sector Pension Investment Board now owns 33,134 shares of the company’s stock valued at $3,062,000 after purchasing an additional 2,409 shares during the period.

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $82.89 on Wednesday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The company has a market cap of $1.25 billion, a P/E ratio of 78.20, a P/E/G ratio of 4.02 and a beta of 1.39. The firm’s fifty day moving average is $83.22 and its two-hundred day moving average is $92.92. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The company had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.76 earnings per share. As a group, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.12%. U.S. Physical Therapy’s payout ratio is currently 166.04%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Bank of America restated a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.